The 32ND International Epilepsy Congress was held in Barcelona, Spain, this past week, and CBD products were a prominent part of the conversation throughout the event.
BOSTON (AP) — Massachusetts’ highest court ruled Tuesday that field sobriety tests typically used in drunken-driving cases cannot be treated as conclusive evidence that a motorist was operating under the influence of marijuana.
Local grower Joseph Snow has developed a natural farming method that he says will meet California’s new mandate for cannabis to be free of pesticides, fungus, and mold.
Researchers found that smoking marijuana during pregnancy doesn’t increase the risk of adverse birth outcomes like preterm birth or the birth of a baby with low weight. However, the findings do not encourage or condone marijuana use when pregnant.
When a pet becomes ill, it can be hard to know what to do. Many owners are weary of giving their pet pharmaceuticals and potentially harmful chemicals.
The world is watching as California comes into the main fold this next year with a full adult legalization policy. The enormity of the market, matched with global regional brand recognition, and California’s propensity for bureaucracy make an interesting confluence for cannabis.
Medical Professionals Brace for Cannabis Prep for Public Effects of Legal Recreational Pot Written by Kelsey Brugger
A group of about 30 law enforcement, medical, and treatment professionals met behind closed doors Wednesday at Cottage Hospital to brace for the full legalization of cannabis.
Colorado official endorses Canada’s delayed approach on legalizing marijuana edibles Written by Brian Platt
Canadian government officials have said they intend to eventually allow edibles, but for now will only allow the smokable products
Insufficient management of cancer-associated chronic and neuropathic pain adversely affects patient quality of life. Patients who do not respond well to opioid analgesics, or have severe side effects from the use of traditional analgesics are in need of alternative therapeutic options. Anecdotal evidence suggests that medical cannabis has potential to effectively manage pain in this patient population. This review presents a selection of representative clinical studies, from small pilot studies conducted in 1975, to double-blind placebo-controlled trials conducted in 2014 that evaluated the efficacy of cannabinoid-based therapies containing tetrahydrocannabinol (THC) and cannabidiol (CBD) for reducing cancer-associated pain. A review of literature published on Medline between 1975 and 2017 identified five clinical studies that evaluated the effect of THC or CBD on controlling cancer pain, which have been reviewed and summarised. Five studies that evaluated THC oil capsules, THC:CBD oromucosal spray (nabiximols), or THC oromucosal sprays found some evidence of cancer pain reduction associated with these therapies.
Cannabis and intractable chronic pain: an explorative retrospective analysis of Italian cohort of 614 patients
In recent years, a number of nations have introduced specific laws to allow patients to use cannabis preparations to treat a variety of medical conditions. In 2015, the Italian government authorised the use of cannabis to treat several diseases, including chronic pain generally, spasticity in multiple sclerosis, cachexia and anorexia among AIDS and cancer patients, glaucoma, Tourette syndrome, and certain types of epilepsy. From this initial snapshot, it was determined that the treatment seems to be effective and safe, although more data and subsequent trials are needed to better investigate its ideal clinical indication.